Droplet Dx: AI enabled Micro-fluidics for Cervical Cancer Screening in LMICs
Droplet Dx: AI enabled Micro-fluidics for Cervical Cancer Screening in LMICs
$15K ddPCR system delivering lab-grade molecular diagnostics at 90% cost reduction. AI-driven platform enables HPV screening, TB, malaria detection in resource-limited settings without specialized labs. Indo-German collaboration (Max Planck, University of Hamburg) with validated commercial interest. Addresses 3+ billion underserved people, preventing thousands of preventable deaths through accessible early disease detection.
Areas of
Research Project
Engineering, Computer Sciences, Human Medicine, Health Sciences
Duration
1-3 Years
Time period of Funding
01-01-1970 - 01-01-1970
Leading Institution
Surfacto Biotech GMBH
22547 Hamburg, Germany, Hamburg, Germany Partners Institution
Vyuhaa Med Data Private Limited
4/608 G1 VOC Street Perungudi, OMR Chennai Neelankarai Chennai City, Chennai, India
https://www.vyuhaadata.com/
